Fig. 3From: Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trialPatient-reported change in bowel habits from baseline to week 4 in OXN-CR-treated patients and OX-CR-treated patients (FAS). aPatients with available data at week 4Back to article page